• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症相关肾脏疾病的临床与分子研究进展

Clinical and molecular insights into tuberous sclerosis complex renal disease.

机构信息

Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, MLC 7022, 3333 Burnet Avenue, Cincinnati, OH, 45229-3039, USA.

出版信息

Pediatr Nephrol. 2011 Jun;26(6):839-52. doi: 10.1007/s00467-010-1689-5. Epub 2010 Dec 9.

DOI:10.1007/s00467-010-1689-5
PMID:21152937
Abstract

Patients with tuberous sclerosis complex are at great risk of developing renal lesions as part of their disease. These lesions include renal cysts and tumors. Significant advances in understanding the cell biology of these renal lesions has already led to clinical trials demonstrating that pharmacological interventions are likely possible. This review focuses on the pathology of these renal lesions, their underlying cell biology, and the possible therapeutic strategies that may prove to significantly improve care for these patients.

摘要

结节性硬化症患者存在发生肾脏病变的巨大风险,这些病变包括肾囊肿和肿瘤。对这些肾脏病变的细胞生物学的深入理解已经取得了重大进展,从而开展了临床试验,表明药物干预很可能是可行的。本综述重点关注这些肾脏病变的病理学、其潜在的细胞生物学以及可能的治疗策略,这些策略可能会显著改善对这些患者的治疗。

相似文献

1
Clinical and molecular insights into tuberous sclerosis complex renal disease.结节性硬化症相关肾脏疾病的临床与分子研究进展
Pediatr Nephrol. 2011 Jun;26(6):839-52. doi: 10.1007/s00467-010-1689-5. Epub 2010 Dec 9.
2
Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.雷帕霉素在与结节性硬化症相关的肾血管平滑肌脂肪瘤中的抗肿瘤活性。
Am J Kidney Dis. 2006 Sep;48(3):e27-9. doi: 10.1053/j.ajkd.2006.05.018.
3
Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.西罗莫司与结节性硬化症相关的肾血管平滑肌脂肪瘤。
Arch Dis Child. 2010 May;95(5):391-2. doi: 10.1136/adc.2009.159210.
4
Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex.结节性硬化症患者肾血管平滑肌脂肪瘤及其他错构瘤的治疗
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1196-1202. doi: 10.2215/CJN.08150816. Epub 2017 Mar 16.
5
Tuberous sclerosis complex, mTOR, and the kidney: report of an NIDDK-sponsored workshop.结节性硬化症复合征、mTOR 和肾脏:NIDDK 主办的研讨会报告。
Am J Physiol Renal Physiol. 2014 Feb 1;306(3):F279-83. doi: 10.1152/ajprenal.00525.2013. Epub 2013 Nov 13.
6
Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action.结节性硬化症相关肾血管平滑肌脂肪瘤:从思考到行动
Nephrol Dial Transplant. 2013 Jul;28(7):1680-5. doi: 10.1093/ndt/gft009. Epub 2013 Feb 14.
7
[Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].[雷帕霉素治疗结节性硬化症相关肾脏疾病]
Zhonghua Er Ke Za Zhi. 2019 Nov 2;57(11):852-856. doi: 10.3760/cma.j.issn.0578-1310.2019.11.007.
8
Regression of renal angiomyolipomas with oral rapamycin therapy in a patient with tuberous sclerosis complex disease.口服雷帕霉素治疗结节性硬化症患者肾血管平滑肌脂肪瘤的疗效观察
Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):545-548. doi: 10.4103/1319-2442.256866.
9
[Recent advance in tuberous sclerosis-related genes and their expression].结节性硬化症相关基因及其表达的最新进展
Zhonghua Bing Li Xue Za Zhi. 2010 Mar;39(3):210-2.
10
Microscopic Kidney Disease in Tuberous Sclerosis Complex and Treatment With mTOR Inhibition.结节性硬化症相关显微镜下肾脏病与 mTOR 抑制治疗
Am J Kidney Dis. 2023 Dec;82(6):772-775. doi: 10.1053/j.ajkd.2023.04.016. Epub 2023 Jul 31.

引用本文的文献

1
Brachial artery aneurysm and bilateral posterior circulation strokes in a young child with tuberous sclerosis complex.小儿结节性硬化症合并肱动脉动脉瘤及双侧后循环卒中。
BMJ Case Rep. 2023 Nov 14;16(11):e255694. doi: 10.1136/bcr-2023-255694.
2
Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model.精氨酸耗竭可减轻结节性硬化症模型中的肾囊肿形成。
Cell Rep Med. 2023 Jun 20;4(6):101073. doi: 10.1016/j.xcrm.2023.101073. Epub 2023 Jun 7.
3
Single Gene Mutations in or Alter Extracellular Vesicle Production and Trafficking.

本文引用的文献

1
Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark.丹麦常染色体显性遗传性多囊肾病患者的预后改善。
Clin J Am Soc Nephrol. 2010 Nov;5(11):2034-9. doi: 10.2215/CJN.01460210. Epub 2010 Jul 29.
2
The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.趋化因子在转移性样淋巴管平滑肌瘤病细胞迁移中的作用。
Crit Rev Immunol. 2010;30(4):387-94. doi: 10.1615/critrevimmunol.v30.i4.40.
3
Glomerulocystic kidney disease.肾小球囊状肾病。
**或**中的单基因突变改变细胞外囊泡的产生和运输。 (注:原文中“in or ”表述不完整,推测可能是有遗漏信息,但按照要求完整翻译了现有内容)
Biology (Basel). 2022 May 6;11(5):709. doi: 10.3390/biology11050709.
4
Benign Renal Tumors in Pediatric Age Group: Retrospective Analysis.小儿年龄组良性肾肿瘤:回顾性分析
J Indian Assoc Pediatr Surg. 2021 Nov-Dec;26(6):380-392. doi: 10.4103/jiaps.JIAPS_214_20. Epub 2021 Nov 12.
5
Rare variant of genetically confirmed tuberous sclerosis complex presenting with bilateral renal angiomyolipoma in Wünderlich syndrome.Wünderlich 综合征中表现为双侧肾血管平滑肌脂肪瘤的基因确诊结节性硬化症的罕见变异型。
BMJ Case Rep. 2021 Aug 3;14(8):e243380. doi: 10.1136/bcr-2021-243380.
6
Renal neoplasms in tuberous sclerosis mice are neurocristopathies.结节性硬化症小鼠的肾肿瘤属于神经嵴病变。
iScience. 2021 Jun 4;24(7):102684. doi: 10.1016/j.isci.2021.102684. eCollection 2021 Jul 23.
7
Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study.依维莫司序贯治疗结节性硬化症相关血管平滑肌脂肪瘤:一项前瞻性队列研究。
Orphanet J Rare Dis. 2021 Jun 14;16(1):277. doi: 10.1186/s13023-021-01913-2.
8
Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex-associated cystic kidney disease.雷帕霉素和地塞米松在孕期可预防结节性硬化症相关囊性肾病。
JCI Insight. 2020 Jul 9;5(13):136857. doi: 10.1172/jci.insight.136857.
9
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.依维莫司对结节性硬化症患者肾功能的影响:来自 EXIST-1 和 EXIST-2 的证据。
Nephrol Dial Transplant. 2019 Jun 1;34(6):1000-1008. doi: 10.1093/ndt/gfy132.
10
Tuberous sclerosis-associated renal angiomyolipoma: A report of two cases and review of the literature.结节性硬化症相关肾血管平滑肌脂肪瘤:两例报告并文献复习
Mol Clin Oncol. 2017 Oct;7(4):706-708. doi: 10.3892/mco.2017.1377. Epub 2017 Aug 14.
Pediatr Nephrol. 2010 Oct;25(10):2049-56; quiz 2056-9. doi: 10.1007/s00467-009-1416-2. Epub 2010 Jan 21.
4
Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.雷帕霉素改善条件性 Pkd1 基因敲除引起的 PKD。
J Am Soc Nephrol. 2010 Mar;21(3):489-97. doi: 10.1681/ASN.2009040421. Epub 2010 Jan 14.
5
Ciliary biology: understanding the cellular and genetic basis of human ciliopathies.纤毛生物学:了解人类纤毛病的细胞和遗传基础。
Am J Med Genet C Semin Med Genet. 2009 Nov 15;151C(4):263-80. doi: 10.1002/ajmg.c.30227.
6
Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.细胞极性缺陷是结节性硬化症和常染色体显性多囊肾病相关囊肿形成的基础。
Hum Mol Genet. 2009 Jun 15;18(12):2166-76. doi: 10.1093/hmg/ddp149. Epub 2009 Mar 25.
7
Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.多囊蛋白-1通过哺乳动物雷帕霉素靶蛋白(mTOR)及其下游效应物核糖体蛋白S6激酶(S6K)和真核翻译起始因子4E结合蛋白1(4EBP1)调节结节性硬化蛋白依赖细胞外信号调节激酶的磷酸化,以控制细胞大小。
Mol Cell Biol. 2009 May;29(9):2359-71. doi: 10.1128/MCB.01259-08. Epub 2009 Mar 2.
8
FGF signalling during embryo development regulates cilia length in diverse epithelia.胚胎发育过程中的成纤维细胞生长因子信号传导调节多种上皮组织中的纤毛长度。
Nature. 2009 Apr 2;458(7238):651-4. doi: 10.1038/nature07753. Epub 2009 Feb 25.
9
Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?结节性硬化症和冯·希佩尔-林道病中的肾脏受累:共同的疾病机制?
Nat Clin Pract Nephrol. 2009 Mar;5(3):143-56. doi: 10.1038/ncpneph1032.
10
Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis.蛋白激酶B决定复制性衰老以及氧化或致癌性过早衰老,并使细胞对氧化凋亡敏感。
Cancer Cell. 2008 Dec 9;14(6):458-70. doi: 10.1016/j.ccr.2008.11.003.